Enlightenment Awaits at Paris ESC Heart-Failure Sessions Enlightenment Awaits at Paris ESC Heart-Failure Sessions
Planned for the meeting in La Ville Lumi è re: Fresh insights on the TRUE-AHF, RELAX-AHF-2, and PARADIGM-HF trials, ICDs in nonischemic disease, and how empagliflozin may have earned its CV indication.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 26, 2017 Category: Cardiology Tags: Cardiology News Source Type: news
Empagliflozin chronic heart failure outcome trials initiated
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - March 17, 2017 Category: Research Source Type: news
Jardiance cardiovascular death EU label update
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - January 26, 2017 Category: Research Source Type: news
Add-on Empagliflozin May Improve Glycemic Control and Weight Add-on Empagliflozin May Improve Glycemic Control and Weight
When type 2 diabetes is uncontrolled with linagliptin and metformin, adding empagliflozin helps improve glycemic control and weight, researchers say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 28, 2016 Category: Surgery Tags: Diabetes & Endocrinology News Source Type: news
' Incredibly Exciting': Diabetes Drug With CV Benefits'Incredibly Exciting': Diabetes Drug With CV Benefits
The FDA ' s recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 21, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
EU Empagliflozin Indication to Be Expanded for CVD Prevention? EU Empagliflozin Indication to Be Expanded for CVD Prevention?
The European Medicines Agency has recommended that the indication for empagliflozin be widened from emphasizing glycemic control to encompassing CVD in type 2 diabetes patients.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 16, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Trying to Live Normally: ADA's 2017 Focus on Whole Patient Trying to Live Normally: ADA's 2017 Focus on Whole Patient
New American Diabetes Association guidelines also address early type 1 diabetes screening, defining hypoglycemia, new roles for empagliflozin and liraglutide, and vitamin B12 deficiency with metformin use.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 16, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
CHMP positive opinion Jardiance reduces risk of cv death
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - December 16, 2016 Category: Research Source Type: news
Jardiance (empagliflozin)
Title: Jardiance (empagliflozin)Category: MedicationsCreated: 12/13/2016 12:00:00 AMLast Editorial Review: 12/13/2016 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - December 13, 2016 Category: Endocrinology Source Type: news
FDA Approves Synjardy XR (empagliflozin/metformin hydrochloride extended-release) for Adults with Type 2 Diabetes
RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 12, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Synjardy XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When used... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 12, 2016 Category: Drugs & Pharmacology Source Type: news
New diabetes guidelines imminent, Jardiance sales may surge
(Reuters) - Two leading U.S. medical societies are poised in the coming weeks to issue new diabetes treatment guidelines reflecting the lifesaving cardiovascular effects of Eli Lilly's Jardiance in a move expected to drive up the drug's sales. (Source: Reuters: Health)
Source: Reuters: Health - December 9, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
Jardiance (Empagliflozin Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 6, 2016 Category: Drugs & Pharmacology Source Type: news
FDA approval Jardiance CV label
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - December 5, 2016 Category: Research Source Type: news
Diabetes Drug Empagliflozin Now Indicated to Reduce CV Mortality Risk (FREE)
By the Editors
Empagliflozin (marketed as Jardiance) is now indicated to reduce the risk for cardiovascular death, the FDA announced on Friday.The new … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 4, 2016 Category: Primary Care Source Type: news
FDA Approves Empagliflozin for Reducing CVD Death FDA Approves Empagliflozin for Reducing CVD Death
The new indication follows the landmark EMPA-REG trial, the first to show that a diabetes drug could reduce death as well as lower blood glucose.FDA Approvals (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 2, 2016 Category: Cardiology Tags: Diabetes & Endocrinology News Alert Source Type: news
